Growth hormone treatment improves body composition in adults with Prader-Willi syndrome

被引:55
作者
Höybye, C
Hilding, A
Jacobsson, H
Thorén, M
机构
[1] Karolinska Hosp & Inst, Dept Endocrinol & Diabet, Stockholm, Sweden
[2] Karolinska Hosp & Inst, Dept Radiol, Stockholm, Sweden
关键词
D O I
10.1046/j.1365-2265.2003.01769.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Low growth hormone (GH) secretion and hypogonadism are common in patients with Prader-Willi syndrome (PWS). In this study we present the effects of GH treatment on body composition and metabolism in adults with PWS. PATIENTS AND MEASUREMENTS Nineteen patients with clinical PWS were recruited, 13 had PWS genotype. They were randomised to treatment with placebo or GH (Genotropin((R)) , Pharmacia Corporation, Sweden) 0.8 IU (0.2 mg) daily for 1 month and then 1.6 IU (0.5 mg) daily for 5 months. Thereafter patients recieved open label treatment so that all had 12 months of active GH treatment. Doses were individually titrated to keep serum IGF-I within the normal range for age. Body composition using dual energy X-ray absorptiometry (DXA), metabolic and endocrinological parameters, including oral glucose tolerance test (OGTT), were studied every 6 months. Seventeen patients, nine men and eight women, 17-32 years of age, with a mean body mass index (BMI) of 35 +/- 3.2 kg/m(2) completed the study. RESULTS Compared to placebo, GH treatment increased IGF-I (P < 0.01) levels and decreased body fat (P = 0.04). When all patients recieved GH treatment a mean reduction in body fat of 2.5% (P < 0.01) concomitant with a mean increase in lean body mass of 2.2 kg (P < 0.05) was seen. Significant changes in body composition were only seen in the patients with the PWS genotype. Lipid profiles were normal in most patients before treatment and did not change. OGTT was impaired in five patients at 12 months, but two of these patients increased in fat mass. Insulin levels were unchanged. According to homeostasis model assessment (HOMA), insulin resistance did not change. Side-effects attributed to water retention occurred in three patients, one of whom had to be given increased diuretic therapy. CONCLUSION This study shows beneficial effects of GH treatment on body composition in adult PWS patients without significant side-effects. Consequently, further studies are encouraged.
引用
收藏
页码:653 / 661
页数:9
相关论文
共 35 条
[1]   Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test [J].
Albareda, M ;
Rodríguez-Espinosa, J ;
Murugo, M ;
de Leiva, A ;
Corcoy, R .
DIABETOLOGIA, 2000, 43 (12) :1507-1511
[2]  
Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379
[3]  
BANG P, 1991, ACTA ENDOCRINOL-COP, V107, P563
[4]   The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults [J].
Bengtsson, BÅ ;
Abs, R ;
Bennmarker, H ;
Monson, JP ;
Feldt-Rasmussen, U ;
Hernberg-Ståhl, E ;
Westberg, B ;
Wilton, P ;
Wüster, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :3929-3935
[5]   THE EFFECT OF GROWTH-HORMONE ADMINISTRATION IN GROWTH-HORMONE DEFICIENT ADULTS ON BONE, PROTEIN, CARBOHYDRATE AND LIPID HOMEOSTASIS, AS WELL AS ON BODY-COMPOSITION [J].
BINNERTS, A ;
SWART, GR ;
WILSON, JHP ;
HOOGERBRUGGE, N ;
POLS, HAP ;
BIRKENHAGER, JC ;
LAMBERTS, SWJ .
CLINICAL ENDOCRINOLOGY, 1992, 37 (01) :79-87
[6]   Prevalence of insulin resistance in metabolic disorders - The Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Targher, G ;
Alberiche, M ;
Bonadonna, RC ;
Muggeo, M .
DIABETES, 1998, 47 (10) :1643-1649
[7]  
Bosio L, 1999, J PEDIATR ENDOCR MET, V12, P351
[8]   Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study [J].
Carrel, AL ;
Myers, SE ;
Whitman, BY ;
Allen, DB .
JOURNAL OF PEDIATRICS, 1999, 134 (02) :215-221
[9]   Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review [J].
Carroll, PV ;
Christ, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) :382-395
[10]   Prader-Willi syndrome [J].
Cassidy, SB .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (11) :917-923